OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC302154 Human cDNA pCMV6-Entry NTRK2 (untagged)-Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e NM_001018066.1 $830 2-3 weeks
RC221890 Human ORF PS100001 NTRK2 (Myc-DDK-tagged)-Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e $670 Immediate
RC221890L1 Human ORF PS100064 Lenti ORF clone of Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e , Myc-DDK-tagged $850 3-4 weeks
RC221890L1V Human ORF PS100064 Lenti ORF particles, NTRK2 (Myc-DDK tagged) - Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e , 200ul, >10^7 TU/mL $1250 6-7 weeks
RC221890L2 Human ORF PS100071 Lenti ORF clone of Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e, mGFP tagged $930 3-4 weeks
RC221890L2V Human ORF PS100071 Lenti ORF particles, NTRK2 (mGFP-tagged) - Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e, 200ul, >10^7 TU/mL $1370 6-7 weeks
RG221890 Human ORF PS100010 NTRK2 (GFP-tagged) - Human neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e $740 2-3 weeks
LY422717 Lysate LC422717 Transient overexpression lysate of neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e $480 5 days
LY425425 Lysate LC425425 Transient overexpression lysate of neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant e $280 5 days
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title